TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | -7 | -6 | -24 | -8 | 0 | 0 | -11 |
| S | %wins | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/12/24 18:00 | 12/10/24 | AVIR | Atea Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Berger Franklin M | MA | D | S | -1,023 | 2.85 | 0 | -360 | -44 | 452 | D | |||||||||||||||
1/5/23 15:41 | 12/14/22 | EPIX | Essa Pharma Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Berger Franklin M | A1 | D | S.m | -729 | 2.67 | 0 | -273 | -29 | 684 | D | |||||||||||||||
11/15/22 20:00 | 11/11/22 | AVIR | Atea Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Berger Franklin M | MA | D | S.m | -215 | 5.15 | 0 | -42 | -5 | 778 | D | |||||||||||||||
12/4/19 18:28 | 12/2/19 | FPRX | Five Prime Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Berger Franklin M | CA | D | S.m | -317 | 3.97 | 0 | -80 | -94 | 5 | D | |||||||||||||||
12/20/16 18:43 | 12/16/16 | IMDZ | Immune Design Corp. | DE | Health | Drug | Pharmaceutical Preparations | Berger Franklin M | WA | D | S | -327 | 6.55 | 1 | -50 | -67 | 25 | D | -75 | -69 | -19 | -5 | 17 | -11 | -17 | -4 | -7 | -6 | -24 | -8 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |